These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21779473)

  • 1. Reduction of human embryonal rhabdomyosarcoma tumor growth by inhibition of the hedgehog signaling pathway.
    Tostar U; Toftgård R; Zaphiropoulos PG; Shimokawa T
    Genes Cancer; 2010 Sep; 1(9):941-51. PubMed ID: 21779473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma.
    Graab U; Hahn H; Fulda S
    Oncotarget; 2015 Apr; 6(11):8722-35. PubMed ID: 25749378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of GLI1 in vincristine-resistant rhabdomyosarcoma and Ewing sarcoma.
    Yoon JW; Lamm M; Chandler C; Iannaccone P; Walterhouse D
    BMC Cancer; 2020 Jun; 20(1):511. PubMed ID: 32493277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hedgehog Inhibitors in Rhabdomyosarcoma: A Comparison of Four Compounds and Responsiveness of Four Cell Lines.
    Ridzewski R; Rettberg D; Dittmann K; Cuvelier N; Fulda S; Hahn H
    Front Oncol; 2015; 5():130. PubMed ID: 26106586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer.
    Mazumdar T; DeVecchio J; Agyeman A; Shi T; Houghton JA
    Oncotarget; 2011 Aug; 2(8):638-45. PubMed ID: 21860067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking Hedgehog survival signaling at the level of the GLI genes induces DNA damage and extensive cell death in human colon carcinoma cells.
    Mazumdar T; Devecchio J; Agyeman A; Shi T; Houghton JA
    Cancer Res; 2011 Sep; 71(17):5904-14. PubMed ID: 21747117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma.
    Zibat A; Missiaglia E; Rosenberger A; Pritchard-Jones K; Shipley J; Hahn H; Fulda S
    Oncogene; 2010 Dec; 29(48):6323-30. PubMed ID: 20818440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis.
    Srivastava RK; Kaylani SZ; Edrees N; Li C; Talwelkar SS; Xu J; Palle K; Pressey JG; Athar M
    Oncotarget; 2014 Dec; 5(23):12151-65. PubMed ID: 25432075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: a report from the Children's Oncology Group.
    Pressey JG; Anderson JR; Crossman DK; Lynch JC; Barr FG
    Pediatr Blood Cancer; 2011 Dec; 57(6):930-8. PubMed ID: 21618411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo.
    Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI
    Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological inhibition of the Hedgehog pathway prevents human rhabdomyosarcoma cell growth.
    Kawabata N; Ijiri K; Ishidou Y; Yamamoto T; Nagao H; Nagano S; Maeda S; Komiya S; Setoguchi T
    Int J Oncol; 2011 Oct; 39(4):899-906. PubMed ID: 21674124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hedgehog signaling drives cellular survival in human colon carcinoma cells.
    Mazumdar T; DeVecchio J; Shi T; Jones J; Agyeman A; Houghton JA
    Cancer Res; 2011 Feb; 71(3):1092-102. PubMed ID: 21135115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclopamine treatment of full-blown Hh/Ptch-associated RMS partially inhibits Hh/Ptch signaling, but not tumor growth.
    Ecke I; Rosenberger A; Obenauer S; Dullin C; Aberger F; Kimmina S; Schweyer S; Hahn H
    Mol Carcinog; 2008 May; 47(5):361-72. PubMed ID: 17963245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gant61 ameliorates CCl
    Jiayuan S; Junyan Y; Xiangzhen W; Zuping L; Jian N; Baowei H; Lifang J
    Toxicol Appl Pharmacol; 2020 Jan; 387():114853. PubMed ID: 31816328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
    You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors.
    Arnhold V; Boos J; Lanvers-Kaminsky C
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):495-505. PubMed ID: 26781311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant GLI1 Activation in DNA Damage Response, Carcinogenesis and Chemoresistance.
    Palle K; Mani C; Tripathi K; Athar M
    Cancers (Basel); 2015 Nov; 7(4):2330-51. PubMed ID: 26633513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus vector-mediated Gli1 siRNA induces growth inhibition and apoptosis in human pancreatic cancer with Smo-dependent or Smo-independent Hh pathway activation in vitro and in vivo.
    Guo J; Gao J; Li Z; Gong Y; Man X; Jin J; Wu H
    Cancer Lett; 2013 Oct; 339(2):185-94. PubMed ID: 23791879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant targeting of Hedgehog signaling and MCL-1 synergistically induces cell death in Hedgehog-driven cancer cells.
    Meister MT; Boedicker C; Linder B; Kögel D; Klingebiel T; Fulda S
    Cancer Lett; 2019 Nov; 465():1-11. PubMed ID: 31465840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors.
    Benvenuto M; Masuelli L; De Smaele E; Fantini M; Mattera R; Cucchi D; Bonanno E; Di Stefano E; Frajese GV; Orlandi A; Screpanti I; Gulino A; Modesti A; Bei R
    Oncotarget; 2016 Feb; 7(8):9250-70. PubMed ID: 26843616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.